Murray Baron

Q: What Schools Are Affiliated With Murray Baron

Murray Baron is affiliated with the following schools: University of California, Berkeley, McGill University, Princeton University, Stanford University

Murray Baron's AcademicInfluence.com Rankings

Murray Baron

Engineering

#7948

World Rank

#9400

Historical Rank

Electrical Engineering

#2477

World Rank

#2596

Historical Rank

engineering Degrees

Murray Baron

Computer Science

#10731

World Rank

#11287

Historical Rank

Data Science

#282

World Rank

#287

Historical Rank

Computational Linguistics

#2700

World Rank

#2729

Historical Rank

Machine Learning

#4892

World Rank

#4949

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

Murray Baron's Degrees

PhD Computer Science Stanford University
Masters Electrical Engineering University of California, Berkeley

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2026

Why Is Murray Baron Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Murray Baron's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. (2013) (2731)
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative (2013) (1713)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial (2016) (429)
Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis (2017) (264)
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate) (2017) (204)
Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. (2011) (195)
Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. (2014) (177)
Depression in patients with systemic sclerosis: a systematic review of the evidence. (2007) (154)
Health services costs and their determinants in women with fibromyalgia. (2004) (151)
Health-related quality of life in systemic sclerosis: a systematic review. (2009) (139)
The 15% Rule in Scleroderma: The Frequency of Severe Organ Complications in Systemic Sclerosis. A Systematic Review (2013) (135)
Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates. (2010) (135)
Associations with digital ulcers in a large cohort of systemic sclerosis: Results from the Canadian Scleroderma Research Group registry (2011) (134)
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis (2017) (129)
Early Mortality in a Multinational Systemic Sclerosis Inception Cohort (2017) (125)
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension (2012) (121)
Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey. (2014) (118)
Malnutrition Is Common in Systemic Sclerosis: Results from the Canadian Scleroderma Research Group Database (2009) (117)
Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis (2019) (114)
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis (2012) (114)
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis (2012) (108)
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index (2016) (106)
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials (2013) (104)
A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis (2007) (104)
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial. (2009) (104)
The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context (2013) (101)
Association of C‐reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research Group (2012) (100)
Gastrointestinal Manifestations of Scleroderma: Recent Progress in Evaluation, Pathogenesis, and Management (2012) (99)
Polyautoimmunity and familial autoimmunity in systemic sclerosis. (2008) (98)
Clinical and Serologic Correlates of Anti‐PM/Scl Antibodies in Systemic Sclerosis: A Multicenter Study of 763 Patients (2014) (95)
Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. (2007) (91)
Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. (2008) (90)
Validation of potential classification criteria for systemic sclerosis (2012) (90)
Psychological health and well‐being in systemic sclerosis: State of the science and consensus research agenda (2010) (90)
Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. (2008) (85)
Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. (2005) (85)
Cigarette smoking in patients with systemic sclerosis. (2011) (81)
ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis (2017) (81)
The needs of patients with arthritis: the patient's perspective. (1999) (80)
Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis (2010) (79)
The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritis. (2008) (79)
Variability of skin scores and clinical measurements in scleroderma. (1995) (78)
Loss of PTEN expression by dermal fibroblasts causes skin fibrosis. (2011) (75)
Corticosteroids and the risk of scleroderma renal crisis: a systematic review (2012) (75)
Systemic Sclerosis: Gastrointestinal Disease and Its Management. (2015) (75)
Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II. (2008) (74)
Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. (2007) (71)
The cost of systemic sclerosis. (2008) (69)
Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis (2017) (68)
Medication non-adherence in women with fibromyalgia. (2004) (67)
The Accuracy of the Patient Health Questionnaire-9 Algorithm for Screening to Detect Major Depression: An Individual Participant Data Meta-Analysis (2019) (66)
Office capillaroscopy in systemic sclerosis (2007) (66)
Quality of Life in Patients with Systemic Sclerosis Compared to the General Population and Patients with Other Chronic Conditions (2009) (65)
The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population. (2014) (65)
2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Outperform the 1980 Criteria: Data From the Canadian Scleroderma Research Group (2015) (65)
Outcome measurements in scleroderma: results from a delphi exercise. (2007) (64)
Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study. (2016) (64)
Screening and therapy for malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel. (2010) (63)
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria. (2014) (62)
Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies (2014) (61)
Update on indices of disease activity in systemic sclerosis. (2007) (61)
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise (2012) (60)
Systemic Sclerosis Sine Scleroderma: A Multicenter Study of 1417 Subjects (2014) (60)
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis (2016) (60)
Work Disability in Systemic Sclerosis (2009) (60)
Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. (2009) (59)
Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) Definition (2017) (58)
Antinuclear antibody-negative systemic sclerosis. (2015) (58)
The development of systemic sclerosis classification criteria (2007) (58)
Are Scores on English and French Versions of the PHQ-9 Comparable? An Assessment of Differential Item Functioning (2012) (58)
Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. (2008) (56)
Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort (2014) (55)
Symptoms of Depression Predict the Trajectory of Pain Among Patients with Early Inflammatory Arthritis: A Path Analysis Approach to Assessing Change (2009) (55)
Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension. (2006) (55)
Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis (2014) (55)
CCL2 in the Circulation Predicts Long‐Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts (2017) (54)
Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblasts. (2012) (51)
Association of Gastroesophageal Factors and Worsening of Forced Vital Capacity in Systemic Sclerosis (2013) (51)
Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study. (2016) (51)
Clinical Correlates of CENP-A and CENP-B Antibodies in a Large Cohort of Patients with Systemic Sclerosis (2012) (51)
Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarction. (2005) (50)
Sociodemographic and Disease Correlates of Body Image Distress among Patients with Systemic Sclerosis (2012) (49)
Hand function in the elderly: relation to osteoarthritis. (1987) (49)
New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN). (2012) (48)
Frailty Index to Measure Health Status in People with Systemic Sclerosis (2014) (47)
The Minimally Important Difference in Clinical Practice for Patient-centered Outcomes Including Health Assessment Questionnaire, Fatigue, Pain, Sleep, Global Visual Analog Scale, and SF-36 in Scleroderma (2010) (47)
Validation of a Novel Radiographic Scoring System for Calcinosis Affecting the Hands of Patients With Systemic Sclerosis (2015) (46)
Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews (2018) (46)
Registries in systemic sclerosis: a worldwide experience. (2011) (46)
Effect of menopause on the modified Rodnan skin score in systemic sclerosis (2014) (45)
Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival. (2015) (45)
Association of pruritus with quality of life and disability in systemic sclerosis (2010) (45)
Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations (2016) (45)
Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival Analysis (2011) (45)
Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension. (2008) (45)
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study (2017) (44)
Systemic Sclerosis: Establishing Diagnostic Criteria (2010) (44)
Patient-physician discordance in fibromyalgia. (2003) (44)
Predictors of Disability and Pain Six Months After the End of Treatment for Fibromyalgia (2010) (43)
Utility of the Patient Health Questionnaire‐9 to Assess Suicide Risk in Patients With Systemic Sclerosis (2013) (42)
Chronic smoke exposure induces rheumatoid factor and anti‐heat shock protein 70 autoantibodies in susceptible mice and humans with lung disease (2012) (42)
The effect of a static wrist orthosis on hand function in individuals with rheumatoid arthritis. (1998) (40)
Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA. (2011) (40)
Development and validation of the brief‐satisfaction with appearance scale for systemic sclerosis (2010) (40)
Prevalence and clinical correlates of pruritus in patients with systemic sclerosis: an updated analysis of 959 patients. (2013) (39)
The Canadian Systemic Sclerosis Oral Health Study IV: oral radiographic manifestations in systemic sclerosis compared with the general population. (2015) (39)
Disability in Systemic Sclerosis — A Longitudinal Observational Study (2011) (37)
The relationship of dyspnoea to function and quality of life in systemic sclerosis (2007) (37)
Late Nailfold Videocapillaroscopy Pattern Associated With Hand Calcinosis and Acro‐Osteolysis in Systemic Sclerosis (2016) (37)
Loss of PPARγ expression by fibroblasts enhances dermal wound closure (2012) (37)
Agreement with Guidelines from a Large Database for Management of Systemic Sclerosis: Results from the Canadian Scleroderma Research Group (2012) (37)
Relationship Between Disease Characteristics and Orofacial Manifestations in Systemic Sclerosis: Canadian Systemic Sclerosis Oral Health Study III (2015) (36)
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis (2016) (36)
CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts (2012) (35)
Sleep disturbances in systemic sclerosis: evidence for the role of gastrointestinal symptoms, pain and pruritus. (2013) (35)
Is Serum Albumin a Marker of Malnutrition in Chronic Disease? The Scleroderma Paradigm (2010) (35)
Time to diagnosis in systemic sclerosis: is sex a factor? (2009) (34)
Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis. (2013) (33)
Static wrist splint use in the performance of daily activities by individuals with rheumatoid arthritis. (2005) (33)
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis (2020) (33)
Distinct bacterial colonization patterns of Escherichia coli subtypes associate with rheumatoid factor status in early inflammatory arthritis. (2010) (33)
Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology (2019) (33)
Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality (2018) (32)
Discordance between Patient and Physician Assessments of Disease Severity in Systemic Sclerosis (2010) (32)
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts (2018) (32)
Validation of the Self‐Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient‐Centered Intervention Network Cohort Study (2016) (32)
Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. (2009) (32)
There is a need for new systemic sclerosis subset criteria. A content analytic approach (2018) (32)
Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality (2018) (32)
High Resolution Computed Tomography Scoring Systems for Evaluating Interstitial Lung Disease in Systemic Sclerosis Patients (2012) (31)
Polymyositis/dermatomyositis: clinical features and outcome in 22 patients. (1985) (31)
The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study. (2016) (31)
Hypocomplementemia in systemic sclerosis--clinical and serological correlations. (2007) (30)
Predictors of health status in women with fibromyalgia: A prospective study (2006) (29)
Defining primary systemic sclerosis heart involvement: A scoping literature review. (2019) (28)
Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects (2015) (28)
Does psychological vulnerability determine health-care utilization in fibromyalgia? (2003) (28)
Influence of somatic symptoms on patient health questionnaire‐9 depression scores among patients with systemic sclerosis compared to a healthy general population sample (2012) (28)
Validation of the UCLA Scleroderma Clinical Trial Gastrointestinal Tract Instrument Version 2.0 for Systemic Sclerosis (2011) (28)
Absence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: a multicenter study of 689 patients. (2014) (26)
Measuring fatigue in SSc: a comparison of the Short Form-36 Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue scale. (2012) (26)
Major Depression Diagnoses Among Patients With Systemic Sclerosis: Baseline and One‐Month Followup (2015) (25)
Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis (2019) (25)
Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues (2016) (25)
Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect. (2015) (24)
Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study (2020) (23)
Autoantibodies to the Rpp25 Component of the Th/To Complex are the Most Common Antibodies in Patients with Systemic Sclerosis without Antibodies Detectable by Widely Available Commercial Tests (2014) (23)
Reports of abnormal cervical cancer screening tests in systemic sclerosis. (2008) (23)
Digital Ulcers in Ssc Treated with Oral Treprostinil: A Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Follow-up (2017) (23)
Clinical correlates of sleep problems in systemic sclerosis: the prominent role of pain. (2011) (22)
Best practices in scleroderma: an analysis of practice variability in SSc centres within the Canadian Scleroderma Research Group (CSRG). (2012) (22)
High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. (2008) (22)
Rates and correlates of sexual activity and impairment among women with systemic sclerosis (2012) (22)
HLA-B27 testing in ankylosing spondylitis: an analysis of the pretesting assumptions. (1989) (22)
Relationship Between Disease Characteristics and Oral Radiologic Findings in Systemic Sclerosis: Results From a Canadian Oral Health Study (2016) (21)
Longitudinal Study of Renal Function in Systemic Sclerosis (2012) (21)
Physical and occupational therapy referral and use among systemic sclerosis patients with impaired hand function: results from a Canadian national survey. (2012) (21)
Prevalence and clinical profiles of 'autoantibody-negative' systemic sclerosis subjects. (2014) (20)
Embolic complications of a mitral valve rheumatoid nodule. (2004) (20)
Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis (2017) (20)
Clinical Correlates of Self-reported Physical Health Status in Systemic Sclerosis (2009) (20)
Measures of disease status in systemic sclerosis: A systematic review. (2017) (19)
What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG) (2010) (19)
Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype. (2018) (19)
Methods for shortening patient-reported outcome measures (2018) (19)
Systemic Sclerosis in Canada’s North American Native Population: Assessment of Clinical and Serological Manifestations (2013) (19)
Congenital Heart Disease in the Adult Patient: The Value of Plain Film Chest Radiology (1995) (19)
Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort. (2018) (18)
Identifying Target Areas of Treatment for Depressed Early Inflammatory Arthritis Patients (2008) (18)
Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian scleroderma research group registry. (2014) (18)
Low Socioeconomic Status (Measured by Education) and Outcomes in Systemic Sclerosis: Data from the Canadian Scleroderma Research Group (2013) (18)
Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients (2020) (18)
Wait Times for Rheumatology Consultation: Is Rheumatoid Arthritis Prioritized? (2012) (18)
Reliability of widefield capillary microscopy to measure nailfold capillary density in systemic sclerosis. (2010) (18)
Sexual Activity and Impairment in Women with Systemic Sclerosis Compared to Women from a General Population Sample (2012) (17)
The Canadian systemic sclerosis oral health study II: the relationship between oral and global health-related quality of life in systemic sclerosis. (2015) (17)
Reasons for non-participation in scleroderma support groups. (2016) (17)
OP0033 Classification Criteria for Systemic Sclerosis: Preliminary Results (2013) (17)
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? (2017) (16)
Measuring Pain in Systemic Sclerosis: Comparison of the Short-form McGill Pain Questionnaire Versus a Single-item Measure of Pain (2011) (16)
Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity. (2019) (16)
Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity. (2019) (16)
Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatment. (2008) (15)
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study. (2019) (15)
Work instability and financial loss in early inflammatory arthritis (2012) (15)
Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients (2016) (15)
Targeted Therapy in Systemic Sclerosis (2016) (15)
A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs) (2017) (15)
Associations with Organ Involvement and Autoantibodies in Systemic Sclerosis: Results from the Canadian Scleroderma Research Group (CSRG) (2013) (14)
Cross-Language Measurement Equivalence of the Center for Epidemiologic Studies Depression (CES-D) Scale in Systemic Sclerosis: A Comparison of Canadian and Dutch Patients (2013) (14)
An International, Web-Based, Prospective Cohort Study to Determine Whether the Use of ACE Inhibitors prior to the Onset of Scleroderma Renal Crisis Is Associated with Worse Outcomes—Methodology and Preliminary Results (2010) (14)
Systemic Sclerosis Immunoglobulin Induces Growth and a Pro-Fibrotic State in Vascular Smooth Muscle Cells through the Epidermal Growth Factor Receptor (2014) (14)
The Association Between Disease Activity and Duration in Systemic Sclerosis (2010) (14)
Heterotopic ossification heralded by a knee effusion. (1983) (14)
Hyperviscosity syndrome in rheumatoid arthritis. (1982) (14)
Oxidative stress-induced senescence mediates inflammatory and fibrotic phenotypes in fibroblasts from systemic sclerosis patients. (2021) (13)
An interim report of the Scleroderma Clinical Trials Consortium working groups (2018) (12)
Toward Understanding of Environmental Risk Factors in Systemic Sclerosis (2020) (12)
Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis (2018) (12)
Modeling smoking in systemic sclerosis: A comparison of different statistical approaches (2011) (12)
Does cigarette smoking mitigate the severity of skin disease in systemic sclerosis? (2013) (12)
Using Marital Status and Continuous Marital Satisfaction Ratings to Predict Depressive Symptoms in Married and Unmarried Women With Systemic Sclerosis: A Canadian Scleroderma Research Group Study (2016) (12)
Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis. (2019) (12)
Assessment of reproductive history in systemic sclerosis. (2008) (12)
Predictors of Adherence to an Integrated Multimodal Program for Fibromyalgia (2008) (11)
Patients with systemic autoimmune diseases could not distinguish comorbidities from their index disease. (2008) (11)
Rapidity of rheumatology consultation for people in an early inflammatory arthritis cohort (2009) (11)
Development and Validation of the Body Concealment Scale for Scleroderma (2016) (11)
The Comparability of English, French and Dutch Scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): An Assessment of Differential Item Functioning in Patients with Systemic Sclerosis (2014) (11)
An Assessment of the Measurement Equivalence of English and French Versions of the Center for Epidemiologic Studies Depression (CES-D) Scale in Systemic Sclerosis (2014) (11)
Subsets in systemic sclerosis: one size does not fit all (2016) (11)
Altered Salivary Redox Homeostasis in Patients with Systemic Sclerosis (2010) (11)
Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort (2017) (11)
The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients (2017) (11)
Summed and Weighted Summary Scores for the Medsger Disease Severity Scale Compared with the Physician’s Global Assessment of Disease Severity in Systemic Sclerosis (2016) (11)
Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1 (2014) (10)
A Delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis using SSc experts and databases. (2013) (10)
Demographic and Clinical Factors Associated with Physician Service Use in Systemic Sclerosis (2008) (10)
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis. (2020) (10)
Evaluation of the clinimetric properties of the Early Inflammatory Arthritis--self-administered comorbidity questionnaire. (2009) (9)
Can Patient‐Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis? (2020) (9)
The challenges and controversies of measuring disease activity in systemic sclerosis (2018) (9)
Neuroarthropathy (Charcot joints) in familial amyloid polyneuropathy. (1981) (8)
Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort (2020) (8)
Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients (2020) (8)
Radionuclide esophageal transit studies in progressive systemic sclerosis: an analysis of longitudinal data. (1991) (8)
Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis – ERRATUM (2019) (8)
Development of the McGill Range of Motion Index (2007) (8)
Anti-HMGCR antibodies in systemic sclerosis (2016) (7)
Better marital adjustment is associated with lower disease activity in early inflammatory arthritis (2012) (7)
Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosis (2013) (7)
Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets (2021) (7)
History of depressive episodes as a risk factor for illness severity in early inflammatory arthritis. (2011) (7)
Understanding itch in systemic sclerosis in order to improve patient quality of life. (2013) (7)
Preliminary Validity of the Barriers to Treatment Adherence Questionnaire in Fibromyalgia: Combining Quantitative and Focus Group Data (2009) (7)
Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis. (2019) (7)
Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study (2020) (7)
SYSTEMIC SCLEROSIS RELATED CALCINOSIS: PATIENTS PROVIDE WHAT SPECIALISTS WANT TO LEARN. (2015) (7)
Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis. (2022) (6)
Parenting disability, parenting stress and child behaviour in early inflammatory arthritis. (2013) (6)
Can the Cancer-related Fatigue Case-definition Criteria Be Applied to Chronic Medical Illness? A Comparison between Breast Cancer and Systemic Sclerosis (2015) (6)
Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS) (2020) (5)
Damage Trajectories in Systemic Sclerosis Using Group‐Based Trajectory Modeling (2022) (5)
Early mortality in Australian, Canadian and Spanish scleroderma patients: rationale for establishing a multi-national inception cohort of patients with systemic sclerosis (2014) (5)
Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS) (2020) (5)
Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health‐Related Quality of Life (2020) (5)
Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis. (2017) (5)
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale. (2021) (5)
An evidence-based strategy to screen for pulmonary arterial hypertension in systemic sclerosis. (2020) (5)
Validity of Self-Reported Comorbidities in Systemic Sclerosis (2009) (4)
The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis (2014) (4)
Assessment of English-French differential item functioning of the Satisfaction with Appearance Scale (SWAP) in systemic sclerosis. (2017) (4)
Immunosuppression for interstitial lung disease in systemic sclerosis – novel insights and opportunities for translational research (2012) (4)
Digital ulcers: should debridement be a standard of care in systemic sclerosis? (2020) (4)
Is there an association between Ro52/TRIM21 antibodies and rheumatoid factor in systemic sclerosis? (2014) (4)
Shoulder hemarthrosis due to a bleeding pseudoaneurysm (2005) (4)
Systemic Sclerosis Classification Criteria: Developing methods for multi-criteria decision analysis with 1000Minds (2014) (4)
rheumatism collaborative initiative rheumatology / European league against sclerosis : an American college of 2013 classification criteria for systemic (2013) (4)
Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: Longitudinal data from the Canadian Scleroderma Research Group (2018) (4)
Small intestinal bacterial overgrowth in systemic sclerosis (2019) (4)
Association between autoantibodies in systemic sclerosis and cancer in a national registry. (2021) (4)
Immunosuppression does not prevent severe gastrointestinal tract involvement in systemic sclerosis. (2021) (4)
Sudden Cardiac Death in Systemic Sclerosis: Diagnostics to Assess Risk and Inform Management (2021) (4)
FRI0372 Early mortality in systemic sclerosis: rationale for forming a multinational inception cohort of patients with scleroderma (the insync study) (2013) (3)
Clinical Correlates Of Lung Scan Abnormalities In Patients With Systemic Sclerosis - Associated Interstitial Lung Disease (2012) (3)
Specificity of Systemic Sclerosis Classification Criteria (2015) (3)
FRI0258 CUMULATIVE INCIDENCE, SURVIVAL AND PREDICTORS OF PULMONARY HYPERTENSION IN SYSTEMIC SCLEROSIS SUBSETS: PAH IS NOT INCREASED IN LIMITED VS DIFFUSE PATIENTS BY ADJUSTED COMPETING RISK ANALYSIS (2020) (3)
Sodium Thiosulfate in Calcinosis (2015) (3)
Estimating Benefits from Immunesuppressive Treatment in Diffuse Cutaneous Systemic Sclerosis: Data from the Canadian Scleroderma Research Group * (2014) (3)
Thearticular manifestations ofprogressive systemic sclerosis (scleroderma) (1982) (3)
Erratum: Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: A systematic review and individual participant data meta-analysis (Journal of Physical Chemistry (2019) DOI: 10.1017/S0033291719001314) (2019) (3)
Joint Estimation of Remission and Response for Methotrexate‐Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta‐Analysis (2019) (3)
NT-proBNP, hs-cTnT, and CRP predict the risk of cardiopulmonary outcomes in systemic sclerosis: Findings from the Canadian Scleroderma Research Group (2021) (3)
187 Temporal pattern of basophil accumulation in cutaneous (2000) (3)
Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort (2019) (3)
FRI0258 CUMULATIVE INCIDENCE, SURVIVAL AND PREDICTORS OF PULMONARY HYPERTENSION IN SYSTEMIC SCLEROSIS SUBSETS: PAH IS NOT INCREASED IN LIMITED VS DIFFUSE PATIENTS BY ADJUSTED COMPETING RISK ANALYSIS (2020) (3)
Exposure to silica and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group (2022) (2)
Caregiving appraisal and disease activity in early inflammatory arthritis. (2013) (2)
Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisis (2019) (2)
Role overload, pain and physical dysfunction in early rheumatoid or undifferentiated inflammatory arthritis in Canada (2012) (2)
Pericardial and Pleural Complications in Systemic Sclerosis (2020) (2)
Corrigendum: ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis (2017) (2)
FRI0241 Association of gastroesophageal factors and progression of interstitial lung disease in the canadian scleroderma research group (CSRG); a large, multi-center database (2013) (2)
Response to: ‘Are autoantibodies to RNA-polymerase III to be incorporated in routine diagnostic laboratory algorithms for systemic autoimmune rheumatic diseases?’ by Jan Damoiseaux (2014) (2)
Predicting lung function decline in systemic sclerosis (SSc) (2010) (2)
Concise report Clinical correlates of sleep problems in systemic sclerosis: the prominent role of pain RHEUMATOLOGY (2011) (2)
Effects of osteopathic manipulative treatment on hand function, disease symptoms and functional status in systemic sclerosis: a series of single-case studies in working women (2016) (2)
Novel Approaches to Discovery of Biomarkers in Rheumatoid Arthritis: Comment on the Article by Oswald et al (2015) (2)
ASSOCIATION BETWEEN IMMUNOSUPPRESSIVE THERAPY AND INCIDENT RISK OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS. (2021) (2)
Observational Data to Study Medication Outcomes in Systemic Sclerosis (2011) (2)
Barriers to Treatment Adherence Questionnaire (2015) (2)
Associations between the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis (CRISS), survival and other disease measures. (2022) (2)
Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis (2021) (1)
Trigeminal neuralgia in systemic sclerosis. (2021) (1)
Reply: To PMID 24577935. (2014) (1)
Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon (2008) (1)
A Pilot Study of a Standardized Rheumatology Referral Form (2014) (1)
FRI0475 Systemic Sclerosis (SSC) Related Calcinosis: Patients Provide what Specialists Want to Learn – Development of a Calcinosis Patient Reported Outcome Measure (PROM) (2015) (1)
Safety and effi cacy of subcutaneous tocilizumab in adults with systemic sclerosis ( faSScinate ) : a phase 2 , randomised , controlled trial (2016) (1)
“From Where I Stand”: using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ) (2021) (1)
AB0727 There is a Need for New Systemic Sclerosis Subset Criteria. A Content Analytic Approach (2015) (1)
Damage indices in rheumatic diseases: A systematic review of the literature. (2019) (1)
Extensive interstitial lung disease in inflammatory myopathy is a strong predictor of mortality (2017) (1)
SAT0202 Early Accrual of Organ Damage in Systemic Sclerosis: Rationale for Forming a Multinational Inception Cohort of Patients with Scleroderma (The Insync Study) (2013) (1)
THU0249 C - reactive protein (CRP) is associated with high disease activity in SSC and ILD. Results from the canadian scleroderma research group (CSRG) (2013) (1)
Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis (2021) (1)
Report from the EULAR ACR Scleroderma Classification Criteria Committee (2012) (1)
Pros and Cons of Echocardiography in the Screening, Diagnosis and Follow-up of Patients with Systemic Sclerosis Pulmonary Arterial Hypertension – a Rheumatologist's Perspective (2017) (1)
Are the Short Form 36 physical and mental component summary scores useful measures in patients with systemic sclerosis? Comment on the article by Rannou et al. (2007) (1)
The Comparability of Functional Assessment of Chronic Illness Therapy - Fatigue Scores between Cancer and Systemic Sclerosis (2017) (1)
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease (2022) (1)
Geographical Distribution of Systemic Sclerosis in Canada: An Ecological Study based on the Canadian Scleroderma Research Group. (2022) (1)
SAT0330 Juvenile Onset Raynaud's Predicts Good Survival in the Canadian Scleroderma Research Group Cohort (2014) (0)
Pain Questionnaire Versus a Single-item Measure of Pain Measuring Pain in Systemic Sclerosis : Comparison of the Short-form McGill (2011) (0)
Comparison Of Different Measures Of Lung Diffusing Capacity For Carbon Monoxide (DLCO) In Systemic Sclerosis (2012) (0)
Comment on: Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse systemic sclerosis: reply. (2020) (0)
Evaluation of Patient and Physician Assessments of Gastrointestinal Disease Activity in Systemic Sclerosis (2022) (0)
POS0888 NON-SURGICAL LOCAL TREATMENTS FOR DIGITAL ULCERS IN SYSTEMIC SCLEROSIS: A SYSTEMATIC LITERATURE REVIEW (2022) (0)
Scleroderma Research Group Database Malnutrition Is Common in Systemic Sclerosis : Results from the Canadian (2009) (0)
Reply: To PMID 23203723. (2014) (0)
THU0006 Trans-ethnic meta-analysis of genome-wide association studies identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis (2017) (0)
Patient‐reported outcome measures in systemic sclerosis: Comment on the article by Hinchcliff et al (2012) (0)
THU0428 Skin score changes in early diffuse cutaneous systemic sclerosis (DCSSC) patients are associated with overall disease severity (2018) (0)
OP0224-HPR Identifying Clinically Significant Fatigue in Rheumatic Diseases: A Case-Definition Approach (2015) (0)
Effect of pregnancy on scleroderma progression (2022) (0)
*Poster 98: Time to Get an Appointment to a Rheumatologist and for Rehabilitation Services: Is Rheumatoid Arthritis Prioritized? (2010) (0)
Hepatic Overlap Syndrome Improved With Infliximab. (2006) (0)
Immunosuppression for interstitial lung disease in systemic sclerosis – novel insights and opportunities for translational research (2012) (0)
Title The Scleroderma Patient-centered Intervention Network ( SPIN ) Cohort : Protocol for a cohort multiple randomised controlled trial ( cmRCT ) design to support trials of psychosocial and rehabilitation interventions in a rare disease context Permalink (2013) (0)
Health Care Utilization in Systemic Sclerosis Patients With Digital Ulcers (2022) (0)
Reply (2014) (0)
Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival Analysis (2011) (0)
Post-natal fibroblast-specific deletion of the Pten gene in fibroblasts induces a scleroderma phenotype (2010) (0)
Special Issue “Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2022” (2023) (0)
Saline Challenge Unmasks Left Ventricular Diastolic Dysfonction In The Majority Of Patients With Pulmonary Hypertension And Scleroderma (2010) (0)
Adult congenital heart disease Edited by William C. Roberts F. A. Davis Company, Philadelphia 752 pages, Illustrated, $75.00 ISBN: 0‐8036‐7420‐ 1 (1988) (0)
Biomarkers of Lung Involvement in Systemic Sclerosis (SSc) (2010) (0)
AB0840 Scleroderma classification criteria: Disease-specific methods for valid case comparisons (2013) (0)
317 Geographical distribution of systemic sclerosis in Canada: A large Canadian database study (2021) (0)
FRI0245 PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC SCLEROSIS IS NEARLY ALWAYS ACCOMPANIED BY A LOW DIFFUSING CAPACITY (2020) (0)
Clinical correlates of sleep problems in systemic sclerosis: The prominent role of pain: (695762011-001) (2011) (0)
Patients with Systemic Sclerosis Clinical Correlates of CENP-A and CENP-B Antibodies in a Large Cohort of Group (2012) (0)
OP0033 European Scleroderma Study Group Activity Index Captures Variations in Disease Activity over Time and Predicts Organ Damage in Early Systemic Sclerosis: Data from The Canadian Scleroderma Research Group (2016) (0)
Immunochip Analysis Identifies New Susceptibility Loci For Systemic Sclerosis: Implications For Pathogenesis (2013) (0)
A 62-Year-Old Woman with Scleroderma and Severe Weight Loss (2011) (0)
AB0598 THE INCREASING USE OF IMMUNOSUPPRESSANTS IN EARLY SYSTEMIC SCLEROSIS (2020) (0)
SAT0481 Setting the standard for longitudinal follow-up of systemic sclerosis; a eustar delphi-based expert consensus (2018) (0)
Association between gastroprotective agents and risk of incident interstitial lung disease in systemic sclerosis. (2021) (0)
Immunosuppression use in early systemic sclerosis may be increasing over time (2021) (0)
Autoantibodies to the hPOP1 and Rpp25/38 Components of the Th/to Complex Identify a Subgroup of Systemic Sclerosis (SSc) Associated Interstitial Lung Disease (ILD) and Antibodies to hPOP1 Are Associated with Reduced Survival (2017) (0)
Endostatin, Potential Biomarkers For Lung Involvement In Subjects With Systemic Sclerosis (2011) (0)
Global Visual Analog Scale , and SF-36 in Scleroderma Outcomes Including Health Assessment Questionnaire , Fatigue , Pain , Sleep , The Minimally Important Difference in Clinical Practice for Patient-centered (2010) (0)
Reply (2014) (0)
025-S: Different Dimensions of Chronic Pain and its Impact on Health Related Quality of Life, Disability and Activity of Daily Living in Early Inflammatory Arthritis (EIA) (2005) (0)
Development of a composite index for clinical trials in early diffuse cutaneous systemic sclerosis - the combined response index in systemic sclerosis (2014) (0)
AB0810 The 15% rule in scleroderma: The frequency of organ complications in systemic sclerosis (SSC). A systematic review (2013) (0)
POS0900 SYSTEMIC PHARMACOLOGICAL TREATMENT OF DIGITAL ULCERS IN SYSTEMIC SCLEROSIS: A SYSTEMATIC LITERATURE REVIEW (2022) (0)
Patient and physician global assessments of disease status in systemic sclerosis. (2022) (0)
Early Inflammatory Arthritis : A Path Analysis Approach to Assessing Change Symptoms of Depression Predict the Trajectory of Pain Among Patients with (2009) (0)
Early accrual of organ damage in scleroderma: rationale for derivation and validation of a disease damage index in systemic sclerosis (2014) (0)
Predicting Lung Function Decline with Serum Pneumoproteins: A Case Control Study (2014) (0)
Skin disorders and interstitial lung disease: Part II. The spectrum of cutaneous diseases with lung disease association. (2022) (0)
THU0233 Myopathy is a poor prognostic feature in systemic sclerosis. Results from the canadian scleroderma research group (CSRG) cohort (2013) (0)
POS0898 SURGICAL MANAGEMENT OF DIGITAL ULCERS IN SYSTEMIC SCLEROSIS: A SYSTEMATIC LITERATURE REVIEW. (2022) (0)
Sleep Disturbances in Scleroderma: Evidence for the Role of Pain and Gastrointestinal Symptoms: (660332012-001) (2012) (0)
OP0209 Soluble Ephrin-B2 Ectodomain Contributes to the Pathogenesis of Systemic Sclerosis (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Murray Baron?

Murray Baron is affiliated with the following schools:

Murray Baron's Academic­Influence.com Rankings

Murray Baron's Degrees

Similar Degrees You Can Earn

Why Is Murray Baron Influential?

Murray Baron's Published Works

Published Works

What Schools Are Affiliated With Murray Baron?

Murray Baron's AcademicInfluence.com Rankings